Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Ophthalmic NSAIDs are becoming a cornerstone for the management of ocular pain and inflammation. Their well-characterized anti-inflammatory activity, analgesic property, and established safety record have also made NSAIDs an important tool for optimizing surgical outcomes. Non-ophthalmic formulations of bromfenac were withdrawn in the US in 1998 due to cases of severe liver toxicity.[L43942,T239]
Synonyms
Bromfenac
Bromfenacum
[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid
Bromfenac sodium
2-amino-3-(4-bromobenzoyl)benzeneacetic acid
Bromfenaco
Brand Names
Bromfenac 0.075%
Bromfenac Ophthalmic Solution
Bromsite 0.075%
Bromfenac Sodium
Bromfenac
Pred Phos-Gati-Brom
Eugia-bromfenac
Bromfenac Ophthalmic Solution, 0.07%
Pred-Gati-Brom
Bromfenac Ophthalmic Solution 0.09%
Bromday
Auro-bromfenac
Yellox
Prolensa
Pred Phos - Brom
Apo-bromfenac
Bromfenac Ophthalmic Solution, 0.09%
Xibrom
Pred-Brom
Indication
For the treatment of postoperative inflammation in patients who have undergone cataract extraction.
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682